1. ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

    ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

    ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced the appointment of Lishan Aklog, M.D. to the Company’s board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned